Literature DB >> 10320774

Repression of the human immunodeficiency virus type 1 promoter by the human KRAB domain results in inhibition of virus production.

O Herchenröder1, J C Hahne, W K Meyer, H J Thiesen, J Schneider.   

Abstract

The Krüppel-associated box (KRAB) domain has been described as a eukaryotic repressor of transcription. We show that fusion of KRAB to DNA-binding-domains provides a novel approach to inhibit expression of a replication-competent human immunodeficiency virus (HIV) genome. The KRAB domain from the human zinc finger protein KOX1 was combined with the DNA binding domain of the Escherichia coli tetracycline repressor (TetR). Constitutive expression of the TetR-KRAB protein in HeLa cells inhibited virus production from an HIV genome encoding TetR target sequences by 80%. The same inhibition was observed with HIV-promoter-driven reporter plasmids. The specificity of inhibition was shown with informative KRAB mutants, plasmids lacking the respective target sequences, and by reversal of the TetR-KRAB-mediated inhibition with tetracycline. Virus production was suppressed by binding of TetR-KRAB at a distance of 6 kbp to the promoter. We therefore conclude that any site of the genuine HIV genome could serve as target of a chimeric KRAB repressor protein. Specific targeting of the KRAB domain by artificially selected binding domains may be generally applicable to control transcription in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320774     DOI: 10.1016/s0167-4781(99)00046-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors.

Authors:  Lindsey Reynolds; Christopher Ullman; Michael Moore; Mark Isalan; Michelle J West; Paul Clapham; Aaron Klug; Yen Choo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

2.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Authors:  Masahide Horiba; Lindsey B Martinez; James L Buescher; Shinji Sato; Jenae Limoges; Yunquan Jiang; Clinton Jones; Tsuneya Ikezu
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein.

Authors:  S Bobadilla; N Sunseri; N R Landau
Journal:  Gene Ther       Date:  2012-08-16       Impact factor: 5.250

Review 4.  Targeting HIV-1 proviral transcription.

Authors:  Alex Olson; Binita Basukala; Wilson W Wong; Andrew J Henderson
Journal:  Curr Opin Virol       Date:  2019-08-29       Impact factor: 7.121

5.  Mycobacterial and HIV infections up-regulated human zinc finger protein 134, a novel positive regulator of HIV-1 LTR activity and viral propagation.

Authors:  Ronald Benjamin; Atoshi Banerjee; Kannan Balakrishnan; Ramya Sivangala; Sumanlatha Gaddam; Sharmistha Banerjee
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  LncRNA AK023948 is a positive regulator of AKT.

Authors:  Pratirodh Koirala; Jianguo Huang; Tsui-Ting Ho; Fangting Wu; Xianfeng Ding; Yin-Yuan Mo
Journal:  Nat Commun       Date:  2017-02-08       Impact factor: 14.919

7.  Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice.

Authors:  Carmen Agustín-Pavón; Michal Mielcarek; Mireia Garriga-Canut; Mark Isalan
Journal:  Mol Neurodegener       Date:  2016-09-06       Impact factor: 14.195

8.  Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.

Authors:  D Chan; T J Wilson; D Xu; H E Cowdery; E Sanij; P J Hertzog; I Kola
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.